Status:
UNKNOWN
Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab
Lead Sponsor:
Qingdao Central Hospital
Conditions:
Pulmonary Fibrosis
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Due to the radiosensitivity of the lung, radiation-induced and chemotherapy-induced pneumonitis and pulmonary fibrosis are frequent happened following cancer therapy. It not only compromise cancer tre...
Eligibility Criteria
Inclusion
- clinical diagnosed cancer treatment-induced acute pulmonary fibrosis
Exclusion
- chronic pulmonary fibrosis and infection-induced pulmonary fibrosis
- active bleeding
- uncontrolled high blood pressure
- unstable systemic disease
- prior exposure to VEGF inhibitor
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01917877
Start Date
August 1 2013
End Date
December 30 2025
Last Update
March 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qingdao Central Hospital
Qingdao, Shandong, China, 266042